FDA Approves the VenaSeal Closure System
FDA Approves the VenaSeal(TM) Closure System for Treatment of Clinically Symptomatic Venous Reflux VenaSeal Closure System, a Next-Generation Chronic Venous Insufficiency Procedure with Demonstrated Safety and Effectiveness DUBLIN – Feb. 24, 2015 - Medtronic plc today announced U.S. Food and Drug Administration approval for VenaSeal(TM) closure system, a minimally invasive procedure that uses a specially…